Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele

For most cancers, Black Americans have the highest death rate and shortest survival of any patient population. And access to genetic testing is key to eliminating this disparity. Feyi Olopade Ayodele is Cofounder and CEO of <a href="https://www.canceriq.com/" target="_blank">CancerIQ</a>, a company on a bold mission to end cancer as we know it by giving providers and health systems access to the latest innovations in early cancer detection and prevention. Under Feyi’s leadership, <a href="https://www.canceriq.com/" target="_blank">CancerIQ</a> has grown its provider network to over 200 locations across the US and established a robust ecosystem of leading diagnostic and genomic testing vendors. On this episode of HLTH Matters, Feyi joins host Dr. Jessica Shepherd to explain how she built CancerIQ to solve for the disparity in access to genetic testing by making it part of everyone’s primary care visit. Feyi describes how CancerIQ helps patients initiate conversations around cancer prevention with their providers and gives providers the right precision prevention program for each patient.  Listen in for Feyi’s insight on the emotional journey associated with a cancer diagnosis and learn how CancerIQ is helping African American and rural patient populations prevent cancer or detect it in its earliest stages. Topics Covered<ul><li>Disparities in breast cancer outcomes between Black women and other patient populations</li><li>Why Feyi built CancerIQ to solve for the disparity in access to genetic testing</li><li>How CancerIQ makes it easy for providers to navigate patients to the right precision cancer prevention program</li><li>Why Feyi encourages primary genetic care vs. specialty genetic care</li><li>How CancerIQ helps patients initiate conversations on cancer prevention with their providers</li><li>How CancerIQ is closing the gap for African American and rural patient populations</li><li>What CancerIQ does to help patients adhere to a cancer prevention plan</li><li>How CancerIQ recognizes the emotional journey associated with a cancer diagnosis</li><li>Feyi’s vision to make CancerIQ part of everyone’s preventative care visit and detect cancer in its earliest stages</li></ul>   Connect with Feyi Olopade Ayodele<a href="https://www.canceriq.com/" target="_blank">CancerIQ</a>  Connect with Dr. Jessica Shepherd<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter</a><a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">Dr. Shepherd on LinkedIn</a>  Resources<a href="https://www.nccn.org/guidelines/category_1" target="_blank">NCCN Guidelines</a><a href="https://open.spotify.com/show/18JVSlByKE0tVPRkYumWgJ" target="_blank">Small Talk Baby Podcast</a>

S3 Ep30: Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele

Co-Founder & CEO

The Beat: Decoding the Future of Healthcare Investment

Investing is both an art and a science, requiring a nuanced blend of strategic thinking and analytical evaluation.In this episode, Josh Flum, Managing Partner at LRVHealth, shares insights into LRVHealth&#39;s unique approach, emphasizing strategic investors as LPs and an integrated model connecting incumbents and innovators. Josh delves into LRVHealth&#39;s investor pattern recognition, focusing on durable trends and long-term value creation. He also provides a nuanced perspective on the current healthcare market and touches on the need for fundamental analysis and the enduring impact of shifts like risk-based insurance models. Josh discusses the complexities of the macroeconomic market, which also presents challenges and opportunities for health tech startups. He strongly advocates for the return to fundamentals and the importance of understanding the evolving healthcare landscape. Finally, Josh expresses his opinion around key themes that will shape the industry, including shifts in insurance models, regulatory changes, and the growing influence of consumerism in healthcare. Tune in to gain valuable insights into the art of venture investing in healthcare and discover where real opportunities lie! About Josh Flum:Josh Flum is a Managing Partner at LRVHealth, a company that invests in healthcare ideas. LRVHealth has a skilled team of healthcare experts and partners with others to support new healthcare companies.  Before LRVHealth, Flum worked for 20 years at CVS Health in different roles. His latest role there was as Chief Strategy &amp; Business Development Officer, where he handled challenges in the changing healthcare world. Flum led significant changes, like combining CVS Health and Aetna and starting CVS Health Ventures, a fund to support new digital health businesses. He played key roles in senior positions, leading growth in CVS Health’s Retail Pharmacy Division through new and smart ideas.  Flum studied at Tufts University and Yale Law School. He began his career working for a U.S. Court of Appeals judge and then at a law firm. Later, he joined the Boston Consulting Group, focusing on the consumer and retail fields. Things You’ll Learn:<ul><li>Investing is both an art and a science, requiring a nuanced blend of strategic thinking and analytical evaluation.</li><li>Market dynamics resemble a pendulum, with current positioning influenced by past trajectories. Understanding this informs future directions and decision-making.</li><li>The surge in digital health solutions during the COVID crisis highlights the transformative potential of technology in healthcare.</li><li>Amid market challenges, it&#39;s crucial to reassess and prioritize the fundamental aspects of healthcare for the coming years.</li><li>There are upcoming changes in how new therapies will be brought to market, commercialized, and integrated into the system for patient access. This includes the exploration of new insurance models to facilitate the payment for these therapies.</li></ul> Resources:<ul><li>Connect with and follow Josh Flum on <a href="https://www.linkedin.com/in/josh-flum-b5153b4/" target="_blank">LinkedIn</a>.</li><li>Follow LRVHealth on <a href="https://www.linkedin.com/company/lrvhealth/" target="_blank">LinkedIn</a> and visit their <a href="https://www.lrvhealth.com/" target="_blank">website</a>.</li></ul>

S1 E5: The Beat: Decoding the Future of Healthcare Investment

Managing Partner

How to Disrupt Healthcare (Responsibly)—featuring Ruby Gadelrab 

Healthcare is a $4 trillion industry just waiting to be disrupted. But because people’s lives are at stake, we must disrupt the space responsibly. And that’s why every digital health company needs clinical experts on their teams and advisory boards. Ruby Gadelrab is Cofounder and CEO of <a href="https://mdisrupt.com/" target="_blank">MDisrupt</a>, a health advisory platform on a mission to organize the world&#39;s digital health products by performance through clinically crowdsourced data generation. Ruby has created a two-sided marketplace that pairs domain experts in healthcare with digital health companies in desperate need of high quality, actionable expertise. On this episode of HLTH Matters, Ruby joins hosts Dr. Jordan Schlain and Dr. Jessica Shepherd to explain why there is so little clinical representation in digital health startups and how MDisrupt pairs health tech companies with the right expert at the right time. Ruby describes how MDisrupt vets clinicians to become part of its health expert network and discusses how clinicians are compensated for their time. Listen in to understand the benefits of a having a medical advisory board and learn how MDisrupt helps health tech innovators accelerate their path to market and drive adoption. Topics Covered <ul><li>Ruby’s take on what it means to disrupt healthcare responsibly</li><li>Why it’s crucial for health tech companies to have clinical expertise on their teams</li><li>How MDisrupt provides an on-demand health expert marketplace</li><li>Ruby’s vision for MDisrupt to organize the world’s digital health products by performance</li><li>How MDisrupt vets clinicians to become part of its health expert network</li><li>How clinicians are compensated for being part of MDisrupt</li><li>Why there is so little clinical representation in digital health startups</li><li>Why health tech companies without medical advisory boards struggle with adoption</li><li>How Ruby’s team pairs a health tech company with the right expert at the right time</li><li>The market insight that inspired Ruby to build MDisrupt</li><li>How to assess your current advisory board and align incentives appropriately</li><li>Leveraging digital health to support underserved populations</li></ul>   Connect with Ruby Gadelrab<a href="https://mdisrupt.com/" target="_blank">MDisrupt</a> Connect with Dr. Jordan Shlain &amp; Dr. Jessica Shepherd<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/DrShlain" target="_blank">Dr. Shlain on Twitter</a><a href="https://www.linkedin.com/in/drjordanshlain/" target="_blank">Dr. Shlain on LinkedIn</a><a href="https://twitter.com/JShepherd_MD" target="_blank">Dr. Shepherd on Twitter</a><a href="https://www.linkedin.com/in/jessica-shepherd-md-mba-5ba9ab66/" target="_blank">Dr. Shepherd on LinkedIn</a> Resources<a href="https://www.instacart.com/company/pressreleases/instacart-launches-instacart-health-a-sweeping-new-initiative-to-deliver-the-ingredients-for-healthier-living/" target="_blank">Instacart Health</a><a href="https://ouraring.com/" target="_blank">Oura Ring</a><a href="https://diabetes.org/tools-support/devices-technology/choosing-cgm" target="_blank">CGM Devices</a><a href="https://www.invitae.com/en" target="_blank">Invitae</a><a href="https://www.23andme.com/" target="_blank">23 and Me</a>

S3 Ep17: How to Disrupt Healthcare (Responsibly)—featuring Ruby Gadelrab 

CEO and Co-founder

How to Be Kind to Your Mind—featuring Russell Glass

The World Health Organization estimates that one billion people have a mental health condition, but 70% of them aren&#39;t getting care. So, what is the best way to address this supply-demand imbalance? How do we help someone with a clinical diagnosis manage their condition? And what can we do to support the mental health needs of people before they develop a serious issue? Russell Glass is CEO of <a href="https://www.headspacehealth.com/" target="_blank">Headspace Health</a>, the world’s most comprehensive and accessible mental health care platform. Russ leads the company in helping create a world where everyone is kind to their mind by way of mindfulness and meditation tools, behavioral health coaching, therapy and psychiatry services. On this episode of HLTH Matters, Russ joins host Dr. Guatam Gulati to explore the root causes of the mental health crisis in the US and explain the benefit of a virtual-first approach to care. Russ discusses how Headspace helps its members get the right level of care and what his team does to alert the appropriate authorities when a user has suicidal or homicidal intent. Listen in for Russ’ insight on the over-prescription of psychotropic drugs like Lexapro and learn how to prevent serious mental health issues with a simple mindfulness and meditation practice. Topics Covered <ul><li>Headspace Health’s mission to transform mental health care</li><li>The supply-demand imbalance that inspired Russ’ work in mental health</li><li>Why Russ takes a broad definition of mental health</li><li>How Headspace offers mindfulness/meditation, behavioral health coaching and therapy services</li><li>When virtual mental health interventions are appropriate and when in-person care works best</li><li>How fast we adopted virtual mental health solutions during COVID</li><li>The root causes of the mental health crisis in the US</li><li>How Headspace helps its members get the right level of care</li><li>How to prevent serious mental health issues with mindfulness and meditation</li><li>How Russ thinks about crime being attributed to the mental health crisis in the US </li><li>What Headspace does to alert the appropriate authorities when a member has suicidal or homicidal intent</li></ul>  Connect with Russell Glass<a href="https://www.headspacehealth.com/" target="_blank">Headspace Health</a>  Connect with Dr. Guatam Gulati<a href="https://www.hlth.com/" target="_blank">HLTH</a><a href="https://twitter.com/drgautamgulati" target="_blank">Dr. Gulati on Twitter</a><a href="https://www.linkedin.com/in/gautamgulati" target="_blank">Dr. Gulati on LinkedIn</a>  Resources<a href="https://www.ginger.com/" target="_blank">Ginger</a><a href="https://health.gov/healthypeople/priority-areas/social-determinants-health" target="_blank">Social Determinants of Health</a><a href="https://www.hiv.uw.edu/page/mental-health-screening/gad-7" target="_blank">Generalized Anxiety Disorder Mental Health Assessment</a><a href="https://cssrs.columbia.edu/the-columbia-scale-c-ssrs/about-the-scale/" target="_blank">Columbia Suicide Severity Rating Scale</a><a href="https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2798510" target="_blank">‘Mindfulness-Based Stress Reduction vs. Escitalopram for the Treatment of Adults with Anxiety Disorders’ in JAMA Psychiatry</a>

S3 Ep15: How to Be Kind to Your Mind—featuring Russell Glass

Podcast

S3 Ep30: Solving for the Disparity in Cancer Outcomes—featuring Feyi Olopade Ayodele

FEATURING